Viewing Study NCT04024683



Ignite Creation Date: 2024-05-06 @ 1:27 PM
Last Modification Date: 2024-10-26 @ 1:14 PM
Study NCT ID: NCT04024683
Status: COMPLETED
Last Update Posted: 2019-07-18
First Post: 2019-07-15

Brief Title: The Effect of the Ultrasound-guided Serratus Anterior Plane Block in Combinaison With Thoracic Paravertebral cathéter Versus Thoracic Paravertebral Cather for Perioperative Analgesia in Thoracic Surgery
Sponsor: Centre Hospitalier Universitaire Dijon
Organization: Centre Hospitalier Universitaire Dijon

Study Overview

Official Title: The Effect of the Ultrasound-guided Serratus Anterior Plane Block in Combinaison With Thoracic Paravertebral cathéter Versus Thoracic Paravertebral Cather for Perioperative Analgesia in Thoracic Surgery
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Introduction

The paravertebral catheter has been shown to be effective in controlling postoperative pain but has never been associated with the deep dentate block in thoracic surgery The objective of this study was to compare the efficacy of single-dose deep dentate block-level postoperative pain control in combination with a continuous perfusion paravertebral catheter versus continuous perfusion paravertebral catheter alone in controlled thoracic surgery

Materials and methods

We retrospectively included 159 ASA I-III major patients who underwent scheduled thoracic surgery in the operating theater of Dijon University Hospital between March and November 2018 All patients benefited from the same anesthetic protocol routinely used in controlled thoracic surgery They were included in two groups deep serrate deep group GS with a deep serrated deep serrate block immediately after orotracheal intubation with 02 Ropivacaine at 075 mg kg and paravertebral catheter placed by the surgeon and put in charge at the fall of the surgical drapes versus control group GC benefiting from a paravertebral catheter alone The primary endpoint was 24-hour morphine equivalent consumption The criteria for secondary judgments were intraoperative remifentanil consumption VAS at 0h 24h and 48h morphine consumption at 0h 48h and the profile of the various complications The morphine equivalent was calculated according to an equivalence table with reference to Oxycodone per os Quantitative data are presented in median and standard deviation and were compared by Students t-test or Wilcoxon test
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None